Citi Upgrades Auxilium Pharmaceuticals (AUXL) to Buy
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Price: $36.47 --0%
Rating Summary:
4 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 9 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Citi upgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Hold to Buy, price target raised from $22 to $25.
For more ratings news on Auxilium Pharmaceuticals click here and for the rating history of Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $14.51 yesterday.
For more ratings news on Auxilium Pharmaceuticals click here and for the rating history of Auxilium Pharmaceuticals click here.
Shares of Auxilium Pharmaceuticals closed at $14.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight
- HSBC Upgrades Digital Realty Trust (DLR) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
